US firm Moderna, which has already taken the lead with another one the BioNTech/Pfizer shot in the global chase for a vaccine, will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, report agencies.
Chief Executive Stephane Bancel made the statement to the German weekly Welt am Sonntag (WamS).
“Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50,” he was quoted as saying.
On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below $25 per dose.
Moderna has said its experimental vaccine is 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.
The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July.